BioStem Technologies (OTC: BSEM)
Wendy Abrantes is currently working as a Staff Accountant and Purchasing Agent at BioStem Technologies since August 2020. Prior to this, Wendy worked as an Accounts Payable Specialist at KRS Global Biotechnology from May 2016 to August 2020, and as an Underwriter and Accounts Receivable at Federal Student Loan Services (FSLS Inc.) from April 2014 to May 2016. Wendy graduated from Florida Atlantic University in December 2021 with a Bachelor of Business Administration in Accounting.
BioStem Technologies (OTC: BSEM)
BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.